{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:20:16Z","timestamp":1789924816223,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/j.cellimm.2011.07.007","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T00:40:53Z","timestamp":1312245653000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis"],"prefix":"10.1016","volume":"271","author":[{"given":"Windy","family":"Allman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2011.07.007_b0005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2011.07.007_b0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2011.07.007_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.07.007_b0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.410430408","article-title":"Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels","volume":"43","author":"Bufler","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Toyka","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2011.07.007_b0035","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2011.07.007_b0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2011.07.007_b0045","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cellimm.2011.07.007_b0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.41.5.394","article-title":"Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications","volume":"41","author":"Lefvert","year":"1978","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cellimm.2011.07.007_b0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2011.07.007_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(85)80045-X","article-title":"Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses","volume":"8","author":"Christadoss","year":"1985","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0960-5428(94)00033-K","article-title":"Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis","volume":"4","author":"Krolick","year":"1994","journal-title":"Adv. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0070","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.69.7.1934","article-title":"Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter","volume":"69","author":"Julius","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2011.07.007_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/eji.1830060410","article-title":"Isolation of antigen-binding cells from unprimed mice. II. Evidence for monospecificity of antigen-binding cells","volume":"6","author":"Julius","year":"1976","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jim.2006.09.005","article-title":"Quantitation of rare memory B cell populations by two independent and complementary approaches","volume":"317","author":"Amanna","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2011.07.007_b0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jneuroim.2006.10.020","article-title":"Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection","volume":"183","author":"Harp","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jim.2005.05.014","article-title":"Enumeration and characterization of virus-specific B cells by multicolor flow cytometry","volume":"303","author":"Doucett","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2011.07.007_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(02)00499-4","article-title":"Identification of an antigen-specific B cell population","volume":"272","author":"Newman","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2011.07.007_b0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdermsci.2008.05.002","article-title":"Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry from the peripheral blood of patients with pemphigus vulgaris","volume":"52","author":"Yamagami","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cellimm.2011.07.007_b0105","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0110","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.175.3.2018","article-title":"IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1","volume":"175","author":"Yang","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0115","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.140.8.2589","article-title":"C5 gene influences the development of murine myasthenia gravis","volume":"140","author":"Christadoss","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1983.tb00446.x","article-title":"Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development","volume":"69","author":"Coffman","year":"1982","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2011.07.007_b0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-3083.1994.tb03395.x","article-title":"Activation signal induces the expression of B cell-specific CD45R epitope (6B2) on murine T cells","volume":"39","author":"Watanabe","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1196\/annals.1405.032","article-title":"Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction","volume":"1132","author":"Fuchs","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.cellimm.2011.07.007_b0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/cdli.2.6.726-732.1995","article-title":"Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients","volume":"726","author":"Hussain","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0140","first-page":"5127","article-title":"Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon","volume":"44","author":"Akiyama","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2011.07.007_b0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1998.4535","article-title":"The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis","volume":"87","author":"Dedhia","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0150","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/intimm\/10.9.1359","article-title":"Experimental autoimmune myasthenia gravis induction in B cell-deficient mice","volume":"10","author":"Li","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0155","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0952-7915(01)00277-1","article-title":"Chemokines in autoimmune disease","volume":"13","author":"Godessart","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0165","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.177.7.4481","article-title":"B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation","volume":"177","author":"Yan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.07.007_b0170","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:48:27Z","timestamp":1757803707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874911001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"alternative-id":["S0008874911001845"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.07.007","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}